---
$id: https://graph.org.ai/products/commodity/51151624
$type: Product
source: UNSPSC
code: "51151624"
title: "Butinoline"
class: "51151600"
classTitle: "Cholinergic blocking agents"
family: "51150000"
familyTitle: "Autonomic nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Butinoline

**UNSPSC Code**: 51151624
**Class**: [Cholinergic blocking agents](Cholinergic blocking agents.mdx)
**Family**: [Autonomic nervous system drugs](../Autonomic nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antimuscarinic agent with the molecular formula C20H21NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier G216926E9T, chemically known as 1,1-diphenyl-4-pyrrolidino-1-yl but-2-yn-1-ol but generally known as butinoline, which bears US NIH Compound Identifier 68943. European Medicines Agency schedules Butinoline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06020MIG. The term BUTINOLINE is an International Non-Proprietary Name. BUTINOLINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule butinoline under HS 29339990 and SITC 51577. As of Q4 2014, BUTINOLINE remains the US FDA Preferred Term for this commodity. Butinoline bears US NLM identifiers UMLS ID C0772190 and NCI Concept Code C78064. SMILES: OC(C1CCCCC1)(C1CCCCC1)C#CCN1CCCC1.

